Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. - Wikidata - awgldk - TriplyDB

Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.

Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.

http://www.wikidata.org/entity/Q33507089

about

Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaedit Intermittent preventive treatment for malaria in children living in areas with seasonal transmission Mass drug administration for malaria Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc)Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial Facilitators and Barriers to Uptake of an Extended Seasonal Malaria Chemoprevention Programme in Ghana: A Qualitative Study of Caregivers and Community Health Workers Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity.The use of formative research to inform the design of a seasonal malaria chemoprevention intervention in northern Nigeria Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial.Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.Intermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and delivery Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children.Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013 Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers.Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.Stability of Dihydroartemisinin-Piperaquine Tablet Halves During Prolonged Storage Under Tropical Conditions.Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.Intermittent preventive treatment against malaria: an update.Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate.Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children.The clinical impact of combining intermittent preventive treatment with home management of malaria in children aged below 5 years: cluster randomised trial.Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger.Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.

P2860

Q21032449-3C77B3FE-36AE-4C3D-8C39-5690E09F3EAE Q21032527-B8331E15-2EC3-42BC-91F0-EFC1AFF01D43 Q24201881-FCE73BA4-F311-46C7-8FA5-68D3A55E6444 Q28125901-236EB53B-F7DA-4B5D-ABAE-F14993667F56 Q28475177-B281F634-B0FD-46E7-8FB6-BA59782FF19C Q28477047-AD322657-D41B-4C57-8A2B-89C338BC0119 Q28477053-7EAF4792-4DDE-4E91-9CD9-339D6F71B7D2 Q28477153-624CEC83-8D27-4A08-824D-36B8F91ED647 Q28477679-69398BFE-6A06-423F-BF89-FD098BE1B8E1 Q28541598-3FD310E3-1FDC-480D-A565-9BD06F072B08 Q28554508-D602100E-8B96-413F-9E7B-D16AE11AB634 Q30245481-EC455492-60DF-4790-9F6C-FBE59D0FB822 Q30381724-8F771329-A44C-45B8-BF2E-8D60B1F7FDA0 Q33589334-33D54CE1-C404-4074-86D3-C2320DDF062F Q33728165-C5BBCBFF-8452-4079-A84B-E284A34C7D5E Q33815505-1D73BFA8-B546-4727-9EB4-6DE78A080C2E Q34025033-0CEEA9C2-487C-495F-BE4A-BE01DDF2508E Q34891749-A79BC8DF-8813-4799-9312-02D1749C0127 Q35746024-4977C420-01F7-4D5C-AC3F-7C8154B8DBE9 Q35746240-84335AF2-752B-4CBE-990F-37A2FF51FBE1 Q35804683-B2698F6C-F597-4E68-BA17-B5F3856116E6 Q35859844-8D1A389C-4724-42A2-84B1-5B11A0AE9C6D Q36018444-7FEA6E5F-971A-4C2D-8A5C-D963C775246B Q36316217-5BF31AB8-2F55-427A-889B-EA57357F3165 Q36617963-DCF12080-089A-4419-A728-DD9A9F5F0416 Q36711959-A7FDFD52-B819-4B18-AA9C-241CE6450FCE Q36743875-34A4F36C-AA42-419A-8EB4-8FDD8DF6E7E9 Q37077079-2B80109B-E5A1-4B85-B8AC-E77B987C0A3C Q37077284-04FE584C-C9B0-4B74-AB6A-A36F81954427 Q37169651-58D5231E-D4F8-4DD5-AE1C-E68938B5810F Q37607325-B1BE9E75-9C49-477D-91D4-B5F190EE640E Q37636852-69F6D8F4-6466-4C9F-A7E1-12C06D4FAC45 Q37726083-C591644A-03CF-4BBC-8C49-FCFF4E7D299E Q37747411-0F99FEF0-493A-430A-9F25-9B79507C9423 Q38152693-E529EE6A-28FE-4601-974A-0B73C8BD157B Q38642887-A1E46561-A8A7-4CBD-8C31-BE2515BEA0E1 Q38928995-BC3B5839-5D67-4A3A-9311-81E3B3CB3AAF Q40340666-FE088D3A-910F-441F-B866-155E9E243A5F Q48023355-233B662D-E1E7-4258-A5C8-B17CA99F3B40 Q50107885-B98DDDE5-092F-4581-A632-F90F73423FC2

P2860

Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.

http://www.wikidata.org/entity/Q33507089

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Randomized trial of piperaquin ...... ventive treatment in children.

@ast

Randomized trial of piperaquin ...... ventive treatment in children.

@en

type

label

Randomized trial of piperaquin ...... ventive treatment in children.

@ast

Randomized trial of piperaquin ...... ventive treatment in children.

@en

prefLabel

Randomized trial of piperaquin ...... ventive treatment in children.

@ast

Randomized trial of piperaquin ...... ventive treatment in children.

@en

P1433

Q33507089-77B5B4A0-F014-492C-A253-D38F41E55B47

P1476

Q33507089-F89F21CF-1FED-4FED-9F1F-1A4EA7C9FF8E

P2093

Q33507089-23926A6F-B447-4B09-9FE5-8E899371D474

Q33507089-23D28722-E946-47D4-BF53-DA9C46133FCC

Q33507089-2C76754E-4DDC-4D50-A724-BE0965851D27

Q33507089-55E0026F-4E62-4258-AC7A-792E8635D279

Q33507089-62750E58-EBB4-48CC-8E1F-2201B2475818

Q33507089-640C477C-2595-45A5-BAAB-0D23D4D2CE7D

Q33507089-8416671C-C985-4EE4-BE9F-F8FB2A6D64F9

Q33507089-853A36A4-81EC-4C60-BC6A-254B285F3C12

Q33507089-9DD70608-C2E6-41ED-B7D6-8A409A475351

Q33507089-AD7AD6C1-4855-4716-8F5B-206D78F60DB2

P2860

Q33507089-1D4D1C8B-7E0D-4757-A664-27071E9942CC

Q33507089-318A162B-CBC7-49DE-82EC-D3B70E237FB4

Q33507089-31CE2EF2-F0F1-4A42-ACD2-D3A835751017

Q33507089-3B5D1225-BB48-4597-823D-47289BEAC57C

Q33507089-3F14D366-B631-4F63-9A28-97AFBD5BC7FA

Q33507089-51457CBF-745D-40B7-A80E-C560CF780D0C

Q33507089-524D2B4B-AFB4-463A-954B-0E73D138EFB3

Q33507089-5F412E67-43D0-4E7F-908E-57122C75D4CB

Q33507089-6EBBEA46-E8E5-49D3-8FD9-9C163BB1553B

Q33507089-9241166A-58C3-41A9-8EC3-0568AA52198F

P304

Q33507089-DA6ACABB-46C3-44D3-9092-00163AD644AF

P31

Q33507089-7649CF64-3A84-41D2-90CE-37344E7A4A07

P356

Q33507089-A7C4D364-FBEA-4CE7-B9F2-460EF6D418F4

P407

Q33507089-7E5B8143-6DCC-4AD0-B772-749FBDFD4B64

P433

Q33507089-4417AF9C-0919-4DB5-B63A-F560A99AD12D

P478

Q33507089-D2422284-4797-42A9-818A-3DB183F90563

P50

Q33507089-2D532801-7C52-448A-82A7-16F08F14BA50

Q33507089-587732CD-41BA-44D9-BDD9-CE10427ADC2E

Q33507089-D42E88CC-6694-49A0-9E7F-C2735532E915

Q33507089-DAAB81B9-C867-46ED-9D8C-CC93A9098483

Q33507089-F08299F6-A051-420B-A6A4-B71E308E7571

P577

Q33507089-6327E179-0354-463D-A546-20943618E64B

P5875

Q33507089-5445F512-20BC-4F12-AB07-FCF6884FCFEE

P698

Q33507089-4504972D-6B1A-4380-906C-3990B7F5AE76

P921

Q33507089-99BDC30C-5C7E-4643-94DE-FC1D0581E079

Q33507089-B54DB0A5-67E8-4FA1-816C-805833C497F9

P932

Q33507089-8DA2DE66-92D5-484C-8C79-B8841864886C

P356

JOURNAL.PONE.0007164

P1433

P1476

Randomized trial of piperaquin ...... ventive treatment in children.

@en

P2093

Babacar Faye

http://www.w3.org/2001/XMLSchema#string

Badara Cisse

http://www.w3.org/2001/XMLSchema#string

Cecile Cames

http://www.w3.org/2001/XMLSchema#string

Ernest Faye

http://www.w3.org/2001/XMLSchema#string

Jean-Francois Trape

http://www.w3.org/2001/XMLSchema#string

Kirsten Simondon

http://www.w3.org/2001/XMLSchema#string

Maguette NDiaye

http://www.w3.org/2001/XMLSchema#string

Matthew Cairns

http://www.w3.org/2001/XMLSchema#string

Oumar Gaye

http://www.w3.org/2001/XMLSchema#string

Ousmane NDiaye

http://www.w3.org/2001/XMLSchema#string

P2860

A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Methods for the analysis of incidence rates in cluster randomized trials.

Efficacy and safety of dihydroartemisinin-piperaquine.

A simple approach to test for interaction between intervention and an individual-level variable in community randomized trials.

Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.

A controlled trial of lambda-cyhalothrin-impregnated bed nets and/or dapsone/pyrimethamine for malaria control in Sierra Leone.

Malaria treatment: no place like home.

Pitfalls in estimating piperaquine elimination.

Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa.

P304

e7164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0007164

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Brian Greenwood

Paul J. Milligan

Jean Louis Ndiaye

Aminata Collé Lô

P577

2009-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26841188

http://www.w3.org/2001/XMLSchema#string

P698

19784374

http://www.w3.org/2001/XMLSchema#string

P921

P932

2747010

http://www.w3.org/2001/XMLSchema#string